Sign in
John C. Rood

John C. Rood

Chairperson, President and Chief Executive Officer at Momentus
CEO
Executive
Board

About John C. Rood

Chairperson, President, and CEO of Momentus Inc. since August 2021; age 56; B.S. in Economics from Arizona State University . Under his tenure, MNTS has continued to secure NASA technology demonstration contracts (e.g., $5.1M COSMIC and $2.5M RDRE awards in Sept. 2025) that support platform validation and potential revenue diversification . MNTS’ pay-versus-performance disclosure shows negative net income and depressed TSR over the last three fiscal years (TSR value of a $100 investment: $18.66 in 2022; $0.83 in 2023; $0.27 in 2024; net loss: $(95.4)mm in 2022, $(68.9)mm in 2023, $(34.9)mm in 2024) .

Past Roles

OrganizationRoleYearsStrategic Impact
U.S. Department of DefenseUndersecretary of Defense for PolicyJan 2018 – Feb 2020Principal advisor on defense policy; led formulation/coordination of national security policy
Lockheed MartinSVP, Lockheed Martin International; VP Corporate Domestic Business DevelopmentMar 2016 – Jan 2018; Jun 2014 – Mar 2016Led international business and domestic BD initiatives
Raytheon CompanyVP U.S. Business DevelopmentMar 2009 – Jun 2014Drove BD across U.S. defense markets
U.S. Department of StateActing Undersecretary for Arms Control & International Security; Assistant Secretary for International Security & NonproliferationSep 2007 – Jan 2009; Oct 2006 – Sep 2007Managed arms control, nonproliferation portfolios
SMA, Inc.; John C. Rood & Associates LLCAssociate; CEO/FounderApr 2020 – Aug 2021; May 2020 – Aug 2021Growth strategies, market analysis, capture support

External Roles

OrganizationRoleYearsNotes
Hitachi Vantara FederalDirectorSince Aug 2021Board service in federal IT solutions
Radisson Hospitality Inc.Security Director; Board ChairJul 2020 – Aug 2022Security oversight; became Chair in Sep 2020

Fixed Compensation

ComponentFY 2024FY 2023FY 2022
Base Salary ($)800,000 800,000 800,000
Target Bonus % of Salary100% 100% 100%
Discretionary Bonus ($)80,000 80,000
All Other Compensation ($)119,310 (housing $79,574; benefits deductions $39,736) 128,175 161,779
Total ($)919,310 2,560,269 2,409,421
  • Employment agreement (Aug 1, 2021): Base $800,000 and annual target cash incentive up to $800,000; reimbursed commuting (including first-class airfare) and temporary housing with tax gross-up on these items until the fourth anniversary of start date; eligible for standard benefits .

Performance Compensation

Incentive TypeMetricWeightingTargetActualPayout MechanicsVesting/Timing
Annual Non-Equity Incentive (2024)Pre-determined company milestones (undisclosed)Not disclosedAchieve measurable milestonesNot disclosedNot disclosedAnnual; prior years show payouts (2023: $800,000; 2022: $800,000)
RSUs (Nov 8, 2021)Time-basedn/aService targetsIn progressVests 25% on Aug 20 of 2023, 2024, 2025 (after 6.25% on Nov 20, 2021 and 18.75% on Aug 20, 2022)As scheduled
RSUs (Mar 20, 2022)Time-basedn/aService targetsIn progressVests in three equal annual installments from grant dateAs scheduled
RSUs (Mar 23, 2023)Time-basedn/aService targetsIn progressVests in three equal annual installments from grant dateAs scheduled
Stock Options (Mar 20, 2022)Time-basedn/aService targetsIn progressVests in equal quarterly installments over three yearsExercisable/unexercisable split shown below
  • Equity plan clawback: Awards are subject to company clawback policy; Administrator may require forfeiture/recoupment for specified events or to comply with laws .

Equity Ownership & Alignment

  • Beneficial ownership (Oct 10, 2025): 2,212 shares of Class A common stock and 555 shares issuable upon exercise of options; less than 1% ownership (14,583,946 shares outstanding) .
  • Hedging policy: Directors, officers, employees prohibited from hedging transactions (e.g., swaps, collars); no pledging disclosure identified .
Outstanding Equity Awards (as of Dec 31, 2024)QuantityVesting/Terms
Options (exercisable)168Grant Mar 20, 2022; quarterly vesting over 3 years; exercise price $1,778; expires Mar 20, 2032
Options (unexercisable)47Same grant as above
RSUs (Nov 8, 2021 unvested)3276.25% vested Nov 20, 2021; 18.75% Aug 20, 2022; 25% each on Aug 20 of 2023, 2024, 2025
RSUs (Mar 20, 2022 unvested)318Three equal annual installments from grant date
RSUs (Mar 23, 2023 unvested)1,200Three equal annual installments from grant date

Employment Terms

  • Severance, no change-in-control (qualifying termination without cause or for good reason): 12 months of base salary plus target annual bonus paid over 12 months; pro-rated annual bonus based on actual performance (lump sum); COBRA premium reimbursements up to 12 months; time-based equity awards vest to the number that would vest through the 12-month anniversary of termination .
  • Change-in-control (double-trigger within 3 months before to 24 months after): Lump sum of 18 months base salary plus 1.5x target annual bonus; lump sum of 150% of pro-rated annual bonus based on actual performance; COBRA premium reimbursements up to 18 months; time-based equity awards vest in full (or vest immediately prior to closing if successor does not assume/continue awards) .
  • At-will employment and eligibility for standard benefits .

Board Governance

  • Roles: CEO and Chairperson (dual role), Class II director (term expires 2026) . Lead Independent Director appointed (Linda J. Reiners) because Chair is not independent .
  • Committee memberships: Rood serves on the Disclosure Committee (members: Mitchel B. Kugler—Chair, Chris Hadfield, John C. Rood) .
  • Independence: All directors other than Rood qualify as independent under Nasdaq rules; Board majority independent .
  • Board activity: 26 meetings in FY 2024; all directors attended at least 75% of meetings .
  • Security Director role: Unique security oversight structure continued post-termination of the National Security Agreement; Security Director is sole member of the Security Committee .

Director Compensation (for context; Rood compensated as CEO)

  • Policy: Outside Directors receive annual cash retainers ($100,000 board; $60,000 Chair; $30,000 Lead Independent Director), committee member/chair retainers (Audit: $20,000 member/$30,000 chair; Compensation: $15,000 member/$22,500 chair; Disclosure: $15,000 member/$22,500 chair; Nominating: $10,000 member/$15,000 chair), and annual RSU grants (initial ~$350,000 vesting over 3 years; annual grant equal to 0.128% of shares outstanding) with accelerated vesting on death/disability/change in control .

Companies’ Financial Performance (context for pay-for-performance alignment)

MetricQ3 2023Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025
Revenue ($)339,000*1,023,000*513,000*1,209,000*107,000*285,000*322,000*191,000*
EBITDA ($)(14,851,000)*(13,618,000)*(8,105,000)*(6,743,000)*(7,379,000)*(6,599,000)*(5,861,000)*(5,621,000)*

Values retrieved from S&P Global.*

Additional performance context (annual):

  • Net Income (Loss): 2022: $(95,444) thousand; 2023: $(68,920) thousand; 2024: $(34,946) thousand .
  • TSR valuation of a fixed $100 investment: 2022 $18.66; 2023 $0.83; 2024 $0.27 .

Compensation Committee Analysis

  • Committee composition: Brian Kabot (Chair), Chris Hadfield, Mitchel B. Kugler; all independent .
  • Consultant: Frederic W. Cook & Co. engaged; no additional services >$120,000; independence considered per Nasdaq/SEC requirements .

Related Party Transactions and Policies

  • No Rood-specific related party transactions disclosed in the provided materials; Company maintains a Code of Business Conduct and related-party transactions policy framework in proxy materials .

Risk Indicators & Red Flags

  • Tax gross-up on commuting and housing reimbursements through the fourth anniversary of start date (shareholder-unfriendly feature) .
  • NASDAQ compliance risk: Reverse split (1-for-14) effected Dec 13, 2024; minimum bid regained; continued listing contingent upon meeting equity requirements by April 15, 2025 .
  • Going concern and liquidity risks; need for substantial additional funding; historical losses .
  • Potential dilution overhang: Stockholder approvals sought and/or executed for Convertible Notes, Inducement Warrants, equity line of credit—each enabling issuance in excess of 19.99% under Nasdaq Rule 5635(d); potential significant dilution and price pressure .
  • Regulatory/export control compliance history and continuing obligations; hedging prohibited for insiders .

Investment Implications

  • Pay-for-performance alignment is stretched: high fixed cash ($800k salary) with prior-year incentive payouts, amid persistent negative EBITDA and net losses; TSR depressed—calling for tighter performance-contingent pay design and disclosure of objective KPIs behind non-equity incentives .
  • Ownership alignment is modest (beneficial stake <1%) with meaningful time-based equity outstanding; hedging prohibited, no pledging disclosed—neutral to slightly positive alignment .
  • Contract terms include robust severance and change-in-control accelerations that can be costly in downside scenarios; tax gross-ups on commuting/housing are governance negatives .
  • Equity overhang and financing structures (ELOC, inducement warrants, convertible notes) suggest ongoing dilution and potential trading pressure; monitor special meeting outcomes and capital structure changes .
  • Execution upside depends on converting NASA/DoD program awards into sustainable revenue and margin improvement; near-term financials remain constrained .